ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,594Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 2888

$1.24M Total Retail Price of All Prescriptions

Rank: 124 out of 2888

853 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 853 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 18,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 820 760 1 1
SIMVASTATIN 812 691 2 2
AMLODIPINE BESYLATE 696 619 3 5
LISINOPRIL 621 539 4 3
OMEPRAZOLE 495 436 5 7
HYDROCODONE-ACETAMINOPHEN 491 440 S3 6 4
WARFARIN SODIUM 400 395 7 22
POTASSIUM CHLORIDE 362 353 8 14
DONEPEZIL HCL 358 355 9 26
PRAVASTATIN SODIUM 339 298 10 12
FUROSEMIDE 337 308 11 6
METFORMIN HCL ER 334 293 12 53
CITALOPRAM HBR 313 281 13 24
TRAMADOL HCL 298 282 14 16
METOPROLOL SUCCINATE 290 261 15 11
GABAPENTIN 290 264 15 13
NAMENDA 283 270 17 34
HYDROCHLOROTHIAZIDE 277 239 18 15
ALENDRONATE SODIUM 265 257 19 23
LOSARTAN POTASSIUM 260 233 20 18
SERTRALINE HCL 252 213 21 27
METOPROLOL TARTRATE 231 214 22 10
LOVASTATIN 225 208 23 41
METFORMIN HCL 210 164 24 8
ATORVASTATIN CALCIUM 202 191 25 9
ZOLPIDEM TARTRATE 191 171 26 17
TAMSULOSIN HCL 187 170 27 29
CARVEDILOL 172 145 28 21
ATENOLOL 170 147 29 25
PANTOPRAZOLE SODIUM 164 131 30 33
SPIRIVA 162 140 31 79
CLOPIDOGREL 158 154 32 30
NEXIUM 154 127 33 19
FLUTICASONE PROPIONATE 153 152 34 32
DIOVAN 147 145 35 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 127 36 28
AMLODIPINE BESYLATE-BENAZEPRIL 145 135 36 67
AZITHROMYCIN 144 135 38 38
TRIAMTERENE-HCTZ 142 142 39 63
TRAZODONE HCL 141 112 40 43
SYNTHROID 139 132 41 52
LOSARTAN-HYDROCHLOROTHIAZIDE 133 130 42 46
LANTUS 126 106 43 45
DIGOXIN 125 125 44 55
PLAVIX 121 117 45 40
MIRTAZAPINE 120 117 46 54
GLIMEPIRIDE 114 105 47 36
BUMETANIDE 113 104 48 203
DIOVAN HCT 109 96 49 61
CIPROFLOXACIN HCL 108 104 50 47
BENAZEPRIL HCL 108 108 50 77
ESCITALOPRAM OXALATE 108 78 50 62
ALLOPURINOL 106 100 53 37
ZETIA 104 104 54 81
ADVAIR DISKUS 103 84 55 60
GLIPIZIDE ER 95 95 56 107
FELODIPINE ER 89 89 57 175
ENALAPRIL MALEATE 89 79 57 49
ROPINIROLE HCL 88 88 59 115
ISOSORBIDE MONONITRATE ER 87 84 60 51
MELOXICAM 86 75 61 31
PAROXETINE HCL 86 78 61 84
LIPITOR 82 74 63 78
PROAIR HFA 80 69 64 71
CLONIDINE HCL 79 55 65 39
PREDNISONE 77 76 66 42
GLIPIZIDE XL 76 67 67 205
PROMETHAZINE HCL 76 69 R 67 96
GLYBURIDE 73 65 R 69 58
EVISTA 69 69 70 125
HYDRALAZINE HCL 67 67 71 59
CRESTOR 67 67 71 20
OXYBUTYNIN CHLORIDE 65 52 73 124
VYTORIN 65 50 73 155
BENICAR HCT 63 52 75 181
RAMIPRIL 62 53 76 73
LYRICA 60 54 77 69
HYDROXYZINE HCL 59 57 R 78 174
BENICAR 58 58 79 138
VENLAFAXINE HCL ER 57 57 80 120
LEVETIRACETAM 56 34 81 103
VESICARE 56 52 81 154
FLUOXETINE HCL 56 40 81 83
NOVOLOG 55 37 84 114
COLCRYS 54 54 85 295
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 51 86 88
LEVOFLOXACIN 53 49 86 57
BUPROPION XL 52 49 88 212
JANTOVEN 52 52 88 163
CYCLOBENZAPRINE HCL 52 46 R 88 68
CYMBALTA 51 36 91 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.